Imatinib mesylate enhances the malignant behavior of human breast carcinoma cells

Cancer Chemotherapy and Pharmacology

Volumn 67, Issue 4, 2011, Pages 919-926

  Rappa, Germana ^a   Anzanello, Fabio ^a   Lorico, Aurelio ^a  

^a NEVADA CANCER INSTITUTE   (United States)

Author keywords

Breast cancer; Cancer stem cells; CD24; Imatinib; Microarray

Indexed keywords

ABELSON KINASE; ANTIMONY; CD24 ANTIGEN; CHLORAMBUCIL; DOXORUBICIN; ETOPOSIDE; HERMES ANTIGEN; IMATINIB; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PACLITAXEL; PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR; WNT PROTEIN;

ABCC3 GENE; ABDOMINAL MASS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CANCER; CACNA1G GENE; CANCER CELL; CARCINOGENICITY; CASP9 GENE; CELL MOTILITY; CELL SURVIVAL; CONTROLLED STUDY; COP1 GENE; DACT1 GENE; DRUG SENSITIVITY; FAIM2 GENE; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; MALIGNANT TRANSFORMATION; MMP9 GENE; MOUSE; NONHUMAN; NTS GENE; PCDHGA11 GENE; PRIORITY JOURNAL; PROMOTER REGION; SLC22A3 GENE;

ANIMALS; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; FEMALE; HUMANS; MICE; MICE, NUDE; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; PIPERAZINES; PROMOTER REGIONS, GENETIC; PROTO-ONCOGENE PROTEINS C-ABL; PYRIMIDINES; RECEPTOR, PLATELET-DERIVED GROWTH FACTOR BETA; WNT PROTEINS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 79954447526     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00280-010-1394-x     Document Type: Article

References (27)

1. A Jemal R Siegel E Ward T Murray J Xu MJ Thun 2007 Cancer statistics, 2007 CA Cancer J Clin 57 43 66 17237035 10.3322/canjclin.57.1.43 (Pubitemid 46148091)
2. BJ Druker S Tamura E Buchdunger S Ohno GM Segal S Fanning J Zimmermann NB Lydon 1996 Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells Nat Med 2 561 566 8616716 10.1038/nm0596-561 1:CAS:528:DyaK28Xislyhs70%3D (Pubitemid 26151518)
3. H Joensuu S Dimitrijevic 2001 Tyrosine kinase inhibitor imatinib (STI571) as an anticancer agent for solid tumours Ann Med 33 451 455 11680792 10.3109/07853890109002093 1:CAS:528:DC%2BD3MXpt1KhsLk%3D (Pubitemid 32959916)
4. M Cristofanilli P Morandi S Krishnamurthy JM Reuben BN Lee D Francis DJ Booser MC Green BK Arun L Pusztai A Lopez R Islam V Valero GN Hortobagyi 2008 Imatinib mesylate (Gleevec) in advanced breast cancer-expressing C-Kit or PDGFR-beta: clinical activity and biological correlations Ann Oncol 19 1713 1719 18515258 10.1093/annonc/mdn352 1:STN:280:DC%2BD1cnhslKnsg%3D%3D
5. HK Chew WE Barlow K Albain D Lew A Gown DF Hayes J Gralow GN Hortobagyi R Livingston 2008 A phase II study of imatinib mesylate and capecitabine in metastatic breast cancer: Southwest oncology group study 0338 Clin Breast Cancer 8 511 515 19073506 10.3816/CBC.2008.n.062 1:CAS:528:DC%2BD1MXhtVGiu7s%3D
6. JT Sims S Ganguly LS Fiore CJ Holler ES Park R Plattner 2009 STI571 sensitizes breast cancer cells to 5-fluorouracil, cisplatin and camptothecin in a cell type-specific manner Biochem Pharmacol 78 249 260 19427998 10.1016/j.bcp.2009.04.007 1:CAS:528:DC%2BD1MXms1Wgs7s%3D
7. G Rappa A Lorico 2010 Phenotypic characterization of mammosphere-forming cells from the human MA-11 breast carcinoma cell line Exp Cell Res 316 9 1576 1586 20074564 10.1016/j.yexcr.2010.01.012 1:CAS:528:DC%2BC3cXmtFCgurg%3D
8. G Rappa O Fodstad A Lorico 2008 The stem cell-associated antigen CD133 (Prominin-1) is a molecular therapeutic target for metastatic melanoma Stem Cells 26 3008 3017 18802032 10.1634/stemcells.2008-0601 1:CAS:528: DC%2BD1MXhtFSktrg%3D
9. MG Lampugnani 1999 Cell migration into a wounded area in vitro Methods Mol Biol 96 177 182 10098136 1:STN:280:DyaK1M7pvVajuw%3D%3D
10. M Cataldi A Gaudino V Lariccia M Russo S Amoroso G di Renzo L Annunziato 2004 Imatinib-mesylate blocks recombinant T-type calcium channels expressed in human embryonic kidney-293 cells by a protein tyrosine kinase-independent mechanism J Pharmacol Exp Ther 309 208 215 14718589 10.1124/jpet.103.061184 1:CAS:528:DC%2BD2cXivFamtLo%3D (Pubitemid 38393132)
11. JS Moreb 2008 Aldehyde dehydrogenase as a marker for stem cells Curr Stem Cell Res Ther 3 237 246 19075754 10.2174/157488808786734006 1:CAS:528:DC%2BD1cXhsVKhsrrJ
12. F Yu H Yao P Zhu X Zhang Q Pan C Gong Y Huang X Hu F Su J Lieberman E Song 2007 Let-7 regulates self renewal and tumorigenicity of breast cancer cells Cell 131 1109 1123 18083101 10.1016/j.cell.2007.10.054 1:CAS:528: DC%2BD1cXksFGgtQ%3D%3D (Pubitemid 350235025)
13. V Levina AM Marrangoni R DeMarco E Gorelik AE Lokshin 2008 Drug-selected human lung cancer stem cells: cytokine network, tumorigenic and metastatic properties PLoS One 3 e3077 18728788 10.1371/journal.pone.0003077
14. X Li MT Lewis J Huang C Gutierrez CK Osborne MF Wu SG Hilsenbeck A Pavlick X Zhang GC Chamness GC Chamness H Wong J Rosen JC Chang 2008 Intrinsic resistance of tumorigenic breast cancer cells to chemotherapy J Natl Cancer Inst 100 672 679 18445819 10.1093/jnci/djn123 1:CAS:528:DC%2BD1cXlslymtbg%3D
15. SA Mani W Guo MJ Liao EN Eaton A Ayyanan AY Zhou M Brooks F Reinhard CC Zhang M Shipitsin LL Campbell K Polyak C Brisken J Yang RA Weinberg 2008 The epithelial-mesenchymal transition generates cells with properties of stem cells Cell 133 704 715 18485877 10.1016/j.cell.2008.03.027 1:CAS:528: DC%2BD1cXmsVOru7w%3D (Pubitemid 351636299)
16. K Cwynarski R Laylor E Macchiarulo J Goldman G Lombardi JV Melo F Dazzi 2004 Imatinib inhibits the activation and proliferation of normal T lymphocytes in vitro Leukemia 18 1332 1339 15190258 10.1038/sj.leu.2403401 1:CAS:528:DC%2BD2cXlvVehsr0%3D (Pubitemid 39136740)
17. R Seggewiss DA Price MA Purbhoo 2008 Immunomodulatory effects of imatinib and second-generation tyrosine kinase inhibitors on T cells and dendritic cells: an update Cytotherapy 10 633 641 18836918 10.1080/14653240802317639 1:CAS:528:DC%2BD1cXhtF2ku7jJ
18. AM Wolf D Wolf H Rumpold S Ludwiczek B Enrich G Gastl G Weiss H Tilg 2005 The kinase inhibitor imatinib mesylate inhibits TNF-{alpha} production in vitro and prevents TNF-dependent acute hepatic inflammation Proc Natl Acad Sci USA 102 13622 13627 16174751 10.1073/pnas.0501758102 1:CAS:528:DC%2BD2MXhtVygtr%2FK (Pubitemid 41420898)
19. S Hu RM Franke KK Filipski C Hu SJ Orwick EA de Bruijn H Burger SD Baker A Sparreboom 2008 Interaction of imatinib with human organic ion carriers Clin Cancer Res 14 3141 3148 18483382 10.1158/1078-0432.CCR-07-4913 1:CAS:528:DC%2BD1cXmtVCmuro%3D
20. JP Radich H Dai M Mao V Oehler J Schelter B Druker C Sawyers N Shah W Stock CL Willman S Friend PS Linsley 2006 Gene expression changes associated with progression and response in chronic myeloid leukemia Proc Natl Acad Sci USA 103 2794 2799 16477019 10.1073/pnas.0510423103 1:CAS:528:DC%2BD28XksF2rtL8%3D
21. M Rechichi A Salvetti B Chelli B Costa E Da Pozzo F Spinetti A Lena M Evangelista G Rainaldi C Martini V Gremigni L Rossi 2008 TSPO over-expression increases motility, transmigration and proliferation properties of C6 rat glioma cells Biochim Biophys Acta 1782 118 125 18190798 1:CAS:528:DC%2BD1cXitVGntbg%3D
22. X Wang M Narayanan JM Bruey D Rigamonti E Cattaneo JC Reed RM Friedlander 2006 Protective role of Cop in Rip2/caspase-1/caspase-4-mediated HeLa cell death Biochim Biophys Acta 1762 742 754 16920334 1:CAS:528:DC%2BD28XptVGmtbk%3D (Pubitemid 44293374)
23. F Souaze S Dupouy V Viardot-Foucault E Bruyneel S Attoub C Gespach A Gompel P Forgez 2006 Expression of neurotensin and NT1 receptor in human breast cancer: a potential role in tumor progression Cancer Res 66 6243 6249 16778199 10.1158/0008-5472.CAN-06-0450 1:CAS:528:DC%2BD28XlvVSkt7k%3D
24. S Dupouy V Viardot-Foucault M Alifano F Souaze G Plu-Bureau M Chaouat A Lavaur D Hugol C Gespach A Gompel P Forgez 2009 The neurotensin receptor-1 pathway contributes to human ductal breast cancer progression PLoS One 4 e4223 19156213 10.1371/journal.pone.0004223
25. C Lindvall W Bu BO Williams Y Li 2007 Wnt signaling, stem cells, and the cellular origin of breast cancer Stem Cell Rev 3 157 168 17873348 10.1007/s12015-007-0025-3 1:CAS:528:DC%2BD2sXhtFantLfI (Pubitemid 350129718)
26. O Dreesen AH Brivanlou 2007 Signaling pathways in cancer and embryonic stem cells Stem Cell Rev 3 7 17 17873377 10.1007/s12015-007-0004-8 1:CAS:528:DC%2BD2sXhtVent7nO (Pubitemid 47472808)
27. M Liu MC Casimiro C Wang LA Shirley X Jiao S Katiyar X Ju Z Li Z Yu J Zhou M Johnson P Fortina T Hyslop JJ Windle RG Pestell 2009 p21CIP1 attenuates Ras- and c-Myc-dependent breast tumor epithelial mesenchymal transition and cancer stem cell-like gene expression in vivo Proc Natl Acad Sci USA 106 19035 19039 19858489 10.1073/pnas.0910009106 1:CAS:528:DC%2BD1MXhsFGlsbjO